$ cat molecule-index.md
# Molecule Index
> Same ingredient. Different brand. Different country. Different price.
Source-backed medicine price notes for the drugs we can verify now; ingredient-first index for the rest.
Onion, Apis Mellif o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Allergy Relief Pellet
Onion, Apis Mellifera, Drosera Rotundifolia, Euphrasia Stricta, Urtica Urens · Oral
Drosera Rotundifol o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Drosera Rotundifolia Kit Refill Pellet
Drosera Rotundifolia · Oral
Antimony Potassium o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Chestal Kids Pellets Pellet
Antimony Potassium Tartrate, Bryonia Alba Root, Protortonia Cacti,Drosera Rotundifolia Whole, Ipecac, Pulsatilla Vulgari · Oral
Antimony Potassium o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Chestal Adult Pellets Pellet
Antimony Potassium Tartrate,Bryonia Alba Root, Protortonia Cacti, Drosera Rotundifolia Whole, Ipecac, Rumex Crispus Root · Oral
Drosera Rotundifol o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Drosera Pellet
Drosera Rotundifolia · Oral
Drosera Rotundifol o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Drosera Rotundifolia Pellet
Drosera Rotundifolia Pellet · Oral
Drosera Rotundifol o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Drosera Rotundifolia Pellet
Drosera Rotundifolia Pellet · Oral
Drosera Rotundifol o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Drosera Rotundifolia Pellet
Drosera Rotundifolia Pellet · Oral
Drosera Rotundifol o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Drosera Rotundifolia Pellet
Drosera Rotundifolia Pellet · Oral
Drosera Rotundifol o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Spasmodic Cough Pellet
Drosera Rotundifolia · Oral
$ cat method.md
Ingredient first, prices second
Now
Index 100,000 drug/package records by active ingredient, brand, route, class hint, source, and risk/price-gap watch signals.
Next
Attach daily country snapshots for US, Canada, UK, India, Mexico, and EU comparator markets.
Later
Track pharmacy-level prices, coupons, cash-pay providers, generic availability, and verified substitution boundaries.